Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Prothrombin | ||
Ligand | BDBM50110377 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEBML_208524 | ||
Ki | 53±n/a nM | ||
Citation | Ho, JZ; Gibson, TS; Semple, JE Novel, potent non-covalent thrombin inhibitors incorporating p(3)-lactam scaffolds. Bioorg Med Chem Lett12:743-8 (2002) [PubMed] | ||
More Info.: | Get all data from this article, Assay Method | ||
Prothrombin | |||
Name: | Prothrombin | ||
Synonyms: | Activation peptide fragment 1 | Activation peptide fragment 2 | Coagulation factor II | F2 | Prothrombin precursor | THRB_HUMAN | Thrombin heavy chain | Thrombin light chain | ||
Type: | Protein | ||
Mol. Mass.: | 70029.57 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P00734 | ||
Residue: | 622 | ||
Sequence: |
| ||
BDBM50110377 | |||
n/a | |||
Name | BDBM50110377 | ||
Synonyms: | 2,3-Dihydro-benzofuran-5-sulfonic acid {(S)-1-[3-(4-amino-cyclohexyl)-2-oxo-propyl]-2-oxo-azepan-3-yl}-amide | CHEMBL164180 | ||
Type | Small organic molecule | ||
Emp. Form. | C23H33N3O5S | ||
Mol. Mass. | 463.59 | ||
SMILES | N[C@H]1CC[C@H](CC(=O)CN2CCCC[C@H](NS(=O)(=O)c3ccc4OCCc4c3)C2=O)CC1 |wU:14.14,4.4,wD:1.0,(19.96,-16.04,;18.83,-15.02,;18.83,-13.47,;17.49,-12.71,;16.16,-13.48,;14.83,-12.71,;14.83,-11.17,;15.71,-9.91,;13.29,-11.05,;12.64,-9.65,;13.62,-8.46,;13.29,-6.97,;11.91,-6.28,;10.51,-6.92,;10.16,-8.42,;8.65,-8.75,;7.21,-9.31,;7.76,-10.75,;6.67,-7.86,;5.87,-10.07,;5.85,-11.61,;4.52,-12.36,;3.19,-11.61,;1.7,-12.06,;.82,-10.79,;1.73,-9.56,;3.2,-10.05,;4.55,-9.28,;11.1,-9.63,;10.43,-11.03,;16.16,-15.02,;17.49,-15.8,)| | ||
Structure |